CompanyTEVANYSETel Aviv

Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries develops generic medicines, biosimilars, and branded pharmaceuticals across neuroscience and immunology.

SEC EDGAR ClinicalTrials.gov dl.us

DEF 14ASep 28Latest SEC filing

Sep 17Latest story

September 2026

FDA clears three labeling supplements for palonosetron, letrozole, carbamazepine

Sep 17Weekly roundup, 3 itemscarbamazepine letrozole

Teva subsidiaries price $3.2 billion and €1.5 billion in new senior notes

Sep 16PartnershipTeva Pharmaceutical Industries Ltd

Teva gets labeling supplement approved for injectable Paclitaxel

Sep 11Regulatory decisionpaclitaxel Teva Pharmaceutical Industries Ltd

Teva prices multi-tranche notes offering to fund redemption of five outstanding bond series

Sep 8FinancingTeva Pharmaceutical Industries Ltd

Actavis Labs FL secures four labeling supplement approvals for bupropion HCl SR

Sep 2Regulatory decisionbupropion Teva Pharmaceutical Industries Ltd

August 2026

Teva gets FDA approval for generic tofacitinib citrate ER; two Claravis labeling supplements cleared

Aug 21Weekly roundup, 3 itemsTeva Pharmaceutical Industries Ltd tofacitinib

FDA clears five ANDA supplements for Teva and Actavis Labs generics, mostly labeling updates

Aug 14Weekly roundup, 5 itemsTeva Pharmaceutical Industries Ltd

Actavis Labs UT's clindamycin/benzoyl peroxide gel ANDA shows FDA approval letter dated August 20, 2

Aug 7Regulatory decisionbenzoyl peroxide clindamycin

July 2026

Teva posts Q2 2026 GAAP loss on Emalex charge, raises innovative brand outlook

Jul 29Quarterly updatedeutetrabenazine fremanezumab-vfrm

Teva gets ANDA approval for sugammadex sodium injection; four mycophenolate REMS updates cleared

Jul 29Weekly roundup, 5 itemsmycophenolate sugammadex

Teva gets ANDA approval for tolvaptan generic; Ziac label updated

Jul 24Weekly roundup, 2 itemsbisoprolol fumarate and hydrochlorothiazide Teva Pharmaceutical Industries Ltd

FDA approves Teva's generic eltrombopag olamine tablets in three strengths

Jul 13Regulatory decisioneltrombopag Teva Pharmaceutical Industries Ltd

FDA approves labeling supplement for Actavis's orally disintegrating risperidone tablets

Jul 1Regulatory decisionrisperidone Teva Pharmaceutical Industries Ltd